Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 9158644)

1.

Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators.

Morocutti C, Amabile G, Fattapposta F, Nicolosi A, Matteoli S, Trappolini M, Cataldo G, Milanesi G, Lavezzari M, Pamparana F, Coccheri S.

Stroke. 1997 May;28(5):1015-21.

2.

Indobufen: an updated review of its use in the management of atherothrombosis.

Bhana N, McClellan KJ.

Drugs Aging. 2001;18(5):369-88. Review.

PMID:
11392445
3.

[Italian Study on Atrial Fibrillation (SIFA): status report].

Amabile G, Matteoli S, Fattapposta F, Lavezzari M, Trappolini M, Heiman F, Morocutti C.

Cardiologia. 1993 Dec;38(12 Suppl 1):327-32. Italian.

PMID:
8020032
5.

Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation.

Pengo V, Zasso A, Barbero F, Banzato A, Nante G, Parissenti L, John N, Noventa F, Dalla Volta S.

Am J Cardiol. 1998 Aug 15;82(4):433-7.

PMID:
9723629
7.
8.

Indobufen in the prevention of thromboembolic complications in patients with heart disease. A randomized, placebo-controlled, double-blind study.

Fornaro G, Rossi P, Mantica PG, Caccia ME, Aralda D, Lavezzari M, Pamparana F, Milanesi G.

Circulation. 1993 Jan;87(1):162-4.

PMID:
8419003
9.

Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.

Pérez-Gómez F, Alegría E, Berjón J, Iriarte JA, Zumalde J, Salvador A, Mataix L; NASPEAF Investigators.

J Am Coll Cardiol. 2004 Oct 19;44(8):1557-66.

10.

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.

Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL; SPORTIF Investigators.

Am Heart J. 2006 Nov;152(5):967-73.

PMID:
17070169
11.

Prevention of stroke in patients with atrial fibrillation.

Olsson SB, Halperin JL.

Semin Vasc Med. 2005 Aug;5(3):285-92. Review.

PMID:
16123916
12.

[Embolic complications in atrial fibrillation. Data of the Studio Italiano Fibrillation Atriale (SIFA)].

[No authors listed]

G Chir. 1995 Mar;16(3):137-9. Italian. No abstract available.

PMID:
7547128
15.
16.

Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.

Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.

Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.

PMID:
19616184
18.
19.

Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation.

Taylor FC, Cohen H, Ebrahim S.

BMJ. 2001 Feb 10;322(7282):321-6. Erratum in: BMJ. 2001 Mar 10;322(7286):587.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk